Showing results (261-270 of 271) with videos related to

Sort By:
Pageof 28
BMC Cancer|October 28, 2016
Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer modelsArgentina Ornelas, Christopher R McCullough, Zhen Lu, et al.
Cell Reports|December 12, 2019
DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS ClustersMargie N Sutton, Zhen Lu, Yao-Cheng Li, et al.
Cancers|August 12, 2023
Gender Differences in a Mouse Model of Hepatocellular Carcinoma Revealed Using Multi-Modal ImagingBrian J Engel, Vincenzo Paolillo, Md Nasir Uddin, et al.
The New England Journal of Medicine|February 11, 2011
A randomized trial of prenatal versus postnatal repair of myelomeningoceleN Scott Adzick, Elizabeth A Thom, Catherine Y Spong, et al.
Cancers|April 21, 2019
DIRAS3-Derived Peptide Inhibits Autophagy in Ovarian Cancer Cells by Binding to Beclin1Margie N Sutton, Gilbert Y Huang, Xiaowen Liang, et al.
Fetal Diagnosis and Therapy|August 21, 2014
Fetal myelomeningocele repair: the post-MOMS experience at the Children's Hospital of PhiladelphiaJulie S Moldenhauer, Shelly Soni, Natalie E Rintoul, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 14, 2012
Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflowMary F Lopez, David A Sarracino, Maryann Vogelsang, et al.
Chemical Science|June 24, 2021
Directed evolution of cyclic peptides for inhibition of autophagyJoshua P Gray, Md Nasir Uddin, Rajan Chaudhari, et al.
Iscience|November 17, 2025
DIRAS3-derived cyclic peptides disrupt KRAS-RAF interaction and KRAS nanoclustering, suppressing KRAS-driven pancreatic and ovarian tumorsJoshua P Gray, Gamze Bildik, Ha-Neul Kim, et al.
Clinical Biochemistry|January 15, 2013
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serumBryan Krastins, Amol Prakash, David A Sarracino, et al.
Pageof 28